Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02583243 · ClinicalTrials.gov registry record
Project BEST: Buprenorphine Entry Into Substance Abuse Treatment
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 209
- Enrollment target
NCT02583243 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 209 participants.
The verdict
NCT02583243 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 209 participants
- Enrollment target
Study Summary
Project BEST is a clinical project funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) to increase treatment to opiate dependent patients with mental illness in New Haven, CT and to prospectively follow everyone enrolled in buprenorphine care for as long as the individual takes buprenorphine to track the success of buprenorphine for the maintenance of opiate dependence.
Interventions
- DRUG Buprenorphine
- BEHAVIORAL MET/CBT based individualized counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2005-05 |
| Est. Completion | 2008-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02583243
The ClinicalTrials.gov registry entry for NCT02583243 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Buprenorphine is the first listed.
NCT02583243 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02583243 about?
NCT02583243 is a clinical study titled "Project BEST: Buprenorphine Entry Into Substance Abuse Treatment". Project BEST is a clinical project funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) to increase treatment to opiate dependent patients with mental illness in New Haven, CT and to prospectively follow everyone enrolled in buprenorphine care for as long as the individua...
What is the current status of trial NCT02583243?
This trial is currently completed. The enrollment target is 209 participants. The study started on 2005-05. Estimated completion is 2008-08.
What interventions are being tested in trial NCT02583243?
The interventions under investigation include: Buprenorphine (DRUG), MET/CBT based individualized counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT02583243?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.